JPRN-UMIN000005843招募中未知
A Multi-center Phase II Study evaluating efficacy and safety of Dasatinib in Patients with newly diagnosed Philadelphia(Ph) chromosome positive Chronic Myeloid Leukemia in chronic phase. - A Multi-center Phase II Study evaluating efficacy and safety of Dasatinib.
Epidemiological and Clinical Research Information Network (ECRIN)0 个研究点目标入组 30 人开始时间: 2011年6月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Previous treatment with TKI or IFN-alpha
研究者
相似试验
进行中（未招募）
1 期
Study assessing if a chemotherapy drug called Cabazitaxel is effective in Patients with certain type of breast cancer (HER2 negative) that has spread to brain that is un treatable.Her-2 negative breast cancer with brain metastasesMedDRA version: 14.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10055113Term: Breast cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-000542-35-GBThe Clatterbridge Cancer Centre NHS Foundation Trust19
已完成
2 期
Efficacy of cabazitaxel in patients with HER2-negative metastatic breast cancerPatients with HER2-negative metastatic breast cancer and having unresectable brain metastases.Malignant neoplasm of breastCancerISRCTN79877830The Clatterbridge Cancer Centre NHS Foundation Trust (UK)19
招募中
1 期
Multicenter Phase 2 study to evaluate the efficacy and safety of Cetuximab in combination with Encorafenib plus Binimetinib as induction treatment in BRAF (V600E) mutated MSS, initially resectable or potentially resectable advanced colorectal cancer: CEBBRA study.BRAF V600E mutated and microsatellite stable (MSS) advanced colorectal cancer (aCRC) initially resectable or potentially resectableMedDRA version: 21.0Level: PTClassification code: 10052360Term: Colorectal adenocarcinoma Class: 100000004864CTIS2022-502413-29-00Asociacion Grupo Tratamiento De Tumores Digestivos70
进行中（未招募）
1 期
A multicenter phase II study evaluating the effect and tolerability of vemurafenib in combination with Pegylated Interferon and Interleukin-2 in patients with metastatic melanoma positive for the BRAF-mutatioEUCTR2013-000773-71-DKDepartment of Oncology, Aarhus University Hospital50
进行中（未招募）
不适用
Study to assess the efficacy and the safetyof front-line therapy (Fludarabine, Cyclophosphamide and Ofatumumab) in young (=65 yrs) patientswith Chronic Lymphocytic Leukemia (CLL)Chronic Lymphocytic LeukemiaEUCTR2011-005329-27-ITG.I.M.EM.A.Gruppo Italiano Malattie Ematologiche dell'Adulto